172@29@17@140!~!172@29@0@53!~!|news|business|earnings|natco-pharma-q3-net-profit-declines-34-to-rs-104-4cr-4936961.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Feb 12, 2020 06:37 PM IST | Source: PTI

Natco Pharma Q3 net profit declines 34% to Rs 104.4cr

Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Natco Pharma on Wednesday reported a 34.46 per cent drop in consolidated net profit to Rs 104.4 crore for the quarter ended December 2019. The company had posted a net profit of Rs 159.3 crore for the corresponding period of the previous fiscal, Natco Pharma said in a filing to BSE.

Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.

"The company continues to face margin pressures in its Hepatitis C portfolio," the filing said.

Close

The company's board has recommended a third interim dividend of Rs 3.50 per equity share of Rs 2 each.

Shares of Natco Pharma closed at Rs 712 per scrip on BSE, down 0.59 per cent from its previous close.
First Published on Feb 12, 2020 06:30 pm
Sections